Peter Brian Leone - Net Worth and Insider Trading
Peter Brian Leone Net Worth
The estimated net worth of Peter Brian Leone is at least $3 Million dollars as of 2024-09-20. Peter Brian Leone is the VP, Strategic Bus. Initiatives of Arrowhead Pharmaceuticals Inc and owns about 130,000 shares of Arrowhead Pharmaceuticals Inc (ARWR) stock worth over $3 Million. Details can be seen in Peter Brian Leone's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Peter Brian Leone has not made any transactions after 2018-10-19 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Peter Brian Leone
Peter Brian Leone Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Peter Brian Leone owns 2 companies in total, including Bicycle Therapeutics PLC (BCYC) , and Arrowhead Pharmaceuticals Inc (ARWR) .
Click here to see the complete history of Peter Brian Leone’s form 4 insider trades.
Insider Ownership Summary of Peter Brian Leone
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| BCYC | Bicycle Therapeutics PLC | 2019-05-22 | Chief Business Officer |
| ARWR | Arrowhead Pharmaceuticals Inc | 2018-10-19 | VP & Strategy & Program Mgmt |
Peter Brian Leone Latest Holdings Summary
Peter Brian Leone currently owns a total of 1 stock. Peter Brian Leone owns 130,000 shares of Arrowhead Pharmaceuticals Inc (ARWR) as of October 19, 2018, with a value of $3 Million.
Latest Holdings of Peter Brian Leone
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ARWR | Arrowhead Pharmaceuticals Inc | 2018-10-19 | 130,000 | 21.03 | 2,733,250 |
Holding Weightings of Peter Brian Leone
Peter Brian Leone Form 4 Trading Tracker
According to the SEC Form 4 filings, Peter Brian Leone has made a total of 0 transactions in Arrowhead Pharmaceuticals Inc (ARWR) over the past 5 years. The most-recent trade in Arrowhead Pharmaceuticals Inc is the sale of 131,137 shares on October 19, 2018, which brought Peter Brian Leone around $2 Million.
Insider Trading History of Peter Brian Leone
- 1
Peter Brian Leone Trading Performance
Peter Brian Leone Ownership Network
Peter Brian Leone Owned Company Details
What does Bicycle Therapeutics PLC do?
Who are the key executives at Bicycle Therapeutics PLC?
Peter Brian Leone is the Chief Business Officer of Bicycle Therapeutics PLC. Other key executives at Bicycle Therapeutics PLC include Chief Operating Officer Michael Skynner , Chief Accounting Officer Travis Alvin Thompson , and Chief Operating Officer Alistair Milnes .
Bicycle Therapeutics PLC (BCYC) Insider Trades Summary
Over the past 18 months, Peter Brian Leone made no insider transaction in Bicycle Therapeutics PLC (BCYC). Other recent insider transactions involving Bicycle Therapeutics PLC (BCYC) include a net sale of 19,509 shares made by Kevin Lee , a net sale of 5,905 shares made by Alistair Milnes , and a net sale of 5,905 shares made by Michael Skynner .
In summary, during the past 3 months, insiders sold 7,268 shares of Bicycle Therapeutics PLC (BCYC) in total and bought 0 shares, with a net sale of 7,268 shares. During the past 18 months, 44,258 shares of Bicycle Therapeutics PLC (BCYC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 44,258 shares.
Bicycle Therapeutics PLC (BCYC)'s detailed insider trading history can be found in Insider Trading Tracker table.
Bicycle Therapeutics PLC Insider Transactions
Peter Brian Leone Mailing Address
Above is the net worth, insider trading, and ownership report for Peter Brian Leone. You might contact Peter Brian Leone via mailing address: 225 South Lake Avenue, Suite 1050, Pasadena Ca 91030.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
